Advanced search
Publication Cover
Pharmacogenomics Volume 19, 2018 - Issue 18
Submit an article Journal homepage
157
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analysis of Outpatient HER2 Testing in New York State Using the statewide Planning and Research Cooperative System

Erik Hefti1 Harrisburg University of Science & Technology, Harrisburg, PA17101, USA
,
David M Jacobs2 Department of Pharmacy Practice, The School of Pharmacy & Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY14214, USA
,
Khyatiben Rana3 East Coast Institute for Research, Jacksonville, FL32216, USA
&
Javier G Blanco4 Department of Pharmaceutical Sciences, The School of Pharmacy & Pharmaceutical Sciences, The State University of New York at Buffalo, 470, Kapoor Hall, Buffalo, NY14214, USACorrespondence[email protected]
Pages 1395-1401 | Received 18 Jul 2018, Accepted 03 Oct 2018, Published online: 06 Nov 2018

References

  • Hamburg MA , CollinsFS . The path to personalized medicine . N. Engl. J. Med.2010 ( 363 ), 301 – 304 ( 2010 ).
  • Shin SH , BodeAM , DongZ . Precision medicine: the foundation of future cancer therapeutics . NPJ Precis. Oncol.1 ( 1 ), 12 ( 2017 ).
  • Krishnamurti U , SilvermanJF . HER2 in breast cancer: a review and update . Adv. Anat. Pathol.21 ( 2 ), 100 – 107 ( 2014 ).
  • Incorvati JA , ShahS , MuY , LuJ . Targeted therapy for HER2 positive breast cancer . J. Hematol. Oncol.6 ( 1 ), 38 ( 2013 ).
  • Lohrisch C , PiccartM . An overview of HER2 . Semin. Oncol.28 ( 6 Suppl. 18 ), 3 – 11 ( 2001 ).
  • Cuadros M , VillegasR . Systematic review of HER2 breast cancer testing . Appl. Immunohistochem. Mol. Morphol.17 ( 1 ), 1 – 7 ( 2009 ).
  • Puhalla S , BrufskyA . Treatment of HER2-positive breast cancer: looking backwards briefly . Lancet Oncol.14 ( 13 ), 1250 – 1251 ( 2013 ).
  • Geyer CE , ForsterJ , LindquistDet al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer . N Engl. J. Med.355 ( 26 ), 2733 – 2743 ( 2006 ).
  • Lynch JA , BerseB , DotsonWD , KhouryMJ , CoomerN , KautterJ . Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data . Genet. Med.19 ( 8 ), 890 ( 2017 ).
  • Statewide Planning and Research Cooperative System (SPARCS) overview ( 2016 ). https://www.health.ny.gov/statistics/sparcs/ .
  • Hefti E , BlancoJG . Documenting pharmacogenomic testing with CPT codes . J. AHIMA87 ( 1 ), 56 – 59 ( 2016 ).
  • Magner D , MirochaJ , GewertzBL . Regional variation in the utilization of carotid endarterectomy . J. Vasc. Surg.49 ( 4 ), 893 – 901 ( 2009 ).
  • Wolff AC , HammondMEH , HicksDGet al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update . J. Clin. Oncol.31 ( 31 ), 3997 – 4013 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.